Company intelligence / Profile preview

Symyoo

Seoul, Seoul, South Koreasymyoo.co.kr ↗

Ownership: Private
Development stage: Commercial

Overview

Symyoo is an established full-service contract research organization with over 15 years of experience and more than 250 clinical studies conducted. It offers comprehensive services from phase I-IV trial management to regulatory affairs and data analytics. The company recently launched the first phase of its integrated digital CTMS platform to streamline clinical operations and data quality.

Therapeutic areas: PsychiatryMen's HealthOncologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Sookmyung Women’s University Research Institute of Pharmaceutical Sciences (RIPS) – strategic research collaboration in basic and translational biomedical sciences signed May 2025

Beyond the preview

Go deeper on Symyoo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symyoo.

Explore the full profile